LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 28 filers reported holding LANTERN PHARMA INC in Q3 2023. The put-call ratio across all filers is 3.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,942 | -39.5% | 12,593 | 0.0% | 0.00% | – |
| Q2 2023 | $71,025 | +16.4% | 12,593 | -0.3% | 0.00% | – |
| Q1 2023 | $60,998 | -20.0% | 12,629 | 0.0% | 0.00% | – |
| Q4 2022 | $76,279 | +27.1% | 12,629 | 0.0% | 0.00% | – |
| Q3 2022 | $60,000 | -16.7% | 12,629 | 0.0% | 0.00% | – |
| Q2 2022 | $72,000 | -20.0% | 12,629 | 0.0% | 0.00% | – |
| Q1 2022 | $90,000 | -10.9% | 12,629 | 0.0% | 0.00% | – |
| Q4 2021 | $101,000 | -28.4% | 12,629 | 0.0% | 0.00% | – |
| Q3 2021 | $141,000 | -23.4% | 12,629 | 0.0% | 0.00% | – |
| Q2 2021 | $184,000 | -19.7% | 12,629 | 0.0% | 0.00% | – |
| Q1 2021 | $229,000 | – | 12,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 336,425 | $2,574,000 | 0.44% |
| Lynwood Capital Management Inc. | 50,000 | $399,000 | 0.38% |
| WOLFF WIESE MAGANA LLC | 34,135 | $272,000 | 0.18% |
| Redmond Asset Management, LLC | 49,187 | $393,000 | 0.11% |
| CARLSON CAPITAL L P | 125,000 | $998,000 | 0.06% |
| Anson Funds Management LP | 64,999 | $519,000 | 0.05% |
| NewEdge Advisors, LLC | 167,106 | $1,334,000 | 0.02% |
| Trexquant Investment LP | 27,970 | $223,000 | 0.01% |
| Jump Financial, LLC | 11,028 | $88,000 | 0.01% |
| Sigma Planning Corp | 17,600 | $140,000 | 0.00% |